| 1 |
33831382 | Effects of memantine and its metabolite Mrz 2/373 on soman-induced inhibition of acetylcholinesterase in vitro. | 2021 Jun 1 |
10 |
| 2 |
34576998 | Conjugation of Aminoadamantane and γ-Carboline Pharmacophores Gives Rise to Unexpected Properties of Multifunctional Ligands. | 2021 Sep 11 |
3 |
| 3 |
34907850 | Antioxidant and anticholinesterase activities of amentoflavone isolated from Ouratea fieldingiana (Gardner) Engl. through in vitro and chemical-quantum studies. | 2021 Dec 15 |
1 |
| 4 |
30819076 | Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease. | 2019 |
2 |
| 5 |
31351393 | A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors. | 2019 Oct 15 |
2 |
| 6 |
24493627 | Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces. | 2014 Oct |
1 |
| 7 |
23098644 | Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients. | 2013 May |
1 |
| 8 |
23593992 | Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? | 2013 Aug |
1 |
| 9 |
24081314 | Drugs for cognitive loss and dementia. | 2013 Oct |
1 |
| 10 |
21671540 | Treatment of Alzheimer disease. | 2011 Jun 15 |
1 |
| 11 |
20104942 | Spotlight on memantine in moderate to severe Alzheimer's disease. | 2010 Feb 1 |
2 |
| 12 |
19739697 | Memantine: a review of its use in moderate to severe Alzheimer's disease. | 2009 Oct |
2 |
| 13 |
16518518 | Anticholinesterase toxicity and oxidative stress. | 2006 Feb 28 |
1 |
| 14 |
15266045 | Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil. | 2004 Sep |
3 |
| 15 |
10737358 | No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. | 2000 Feb 11 |
2 |